SMTL ID : 6h1i.1

Crystal structure of human Pirin in complex with bisamide compound 2

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x FE: FE (III) ION(Non-covalent)

FE.1: 4 residues within 4Å: Chain A: H.59, H.61, H.104, E.106 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.59, A:H.61, A:H.104, A:E.106, H2O.1, H2O.4

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: S.125, E.251, P.252, N.262, T.263, E.266 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.125 GOL.3: 8 residues within 4Å: Chain A: Y.69, L.70, L.71, G.91, S.139, D.176, K.178, H.240 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:Y.69, A:L.70, A:S.139, A:S.139, A:K.178, A:H.240 Water bridges: A:E.72 GOL.4: 7 residues within 4Å: Chain A: E.18, R.26, V.27, R.28, E.47, F.48, K.49 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:R.26, A:R.28, A:K.49 Water bridges: A:E.18, A:E.18

1 x FJH: ~{N}-[5-(2,3-dihydro-1,4-benzodioxin-6-ylcarbonylamino)-2-methyl-phenyl]-2-methyl-quinoline-6-carboxamide(Non-covalent)

FJH.5: 17 residues within 4Å: Chain A: E.21, G.22, V.23, R.29, L.44, D.46, F.48, F.56, P.57, H.59, S.68, M.76, E.106, G.116, L.117, Q.118, W.120 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:E.21, A:V.23, A:L.44, A:D.46, A:F.48, A:F.56, A:H.59, A:Q.118, A:W.120, A:W.120 Hydrogen bonds: A:E.21, A:D.46, A:D.46 pi-Stacking: A:F.56

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Meyers, J. et al., Privileged Structures and Polypharmacology within and between Protein Families. ACS Med Chem Lett (2018)

Release Date

2018-11-28

Peptides

Pirin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Pirin

Related Entries With Identical Sequence